ArticleCancers2023

Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation.

Kana Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.